After incubation with ZOL or BMS3, FMNL2 expression was profoundly improved in MDA-MB-231 and BT549 controls, implying that FMNL2 elevation may be involved in ZOL or BMS3-induced suppressive role in breast cancer cell migration. Here, FMNL2 is linked to breast carcinoma.